Heterocyclic Host Material for Balanced OLED Charge Injection

The patent employs composite heterocyclic molecular structures combining pyrido[2,3-b]indole core with triazine groups and aromatic substituents (Ar1, Ar2). This composite structure integrates electron-deficient triazine units with electron-rich heterocyclic frameworks, creating materials that simultaneously achieve high electron transport capability and balanced charge injection, thereby resolving the contradiction between luminous efficiency and structural complexity

The patent systematically varies molecular parameters including substituent types (Ar1, Ar2), substituent positions, and heteroatom configurations (X = C, N, O, S, Si) to optimize electronic properties. By adjusting these parameters, the material achieves optimal HOMO-LUMO energy levels, electron affinity, and mobility characteristics that enhance luminous efficiency without requiring overly complex device architectures

The patent introduces electron-deficient triazine groups at specific local positions within the heterocyclic framework, creating localized electron-accepting centers that enhance electron transport in specific regions while the overall molecular symmetry and substituent distribution maintain balanced charge injection. This local functional differentiation resolves the contradiction between high electron mobility and charge balance

The heterocyclic core structure acts as an intermediary between electron-rich and electron-poor regions, facilitating balanced charge transport. The pyrido[2,3-b]indole core with its specific HOMO-LUMO energy levels mediates between hole injection from the anode and electron injection from the cathode, while the triazine groups provide enhanced electron affinity, achieving both high electron transport and charge balance